The XTANDI QUICK START+® Program provides a one-time, 14-day supply of XTANDI® (enzalutamide) at no cost to new eligible patients who experience a delay in insurance coverage.

  • Patient eligibility requirements for this program include but are not limited to:
    • Have prescription drug insurance
    • Be new to XTANDI therapy
    • Have experienced an insurance-related access delay
    • Have been prescribed XTANDI for an FDA-approved indication
  • Offers overnight shipping directly to the patient

QUICK START+® is a registered trademark of Astellas US LLC.

XTANDI® is a registered trademark of Astellas Pharma Inc.